Skip to content
The Policy VaultThe Policy Vault

MavyretMedica

Genotype 2 or 3 recurrent hepatitis C virus post‑liver transplantation – new start

Initial criteria

  • Patient has met the Hepatitis C – Mavyret PA for PSM Policy criteria

Approval duration

as specified in the Hepatitis C – Mavyret PA for PSM Policy